Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy

This is an Open-Label, Dose-Escalation and Expansion, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of IMC-002 in Patients with Advanced Cancer Failed to Standard Therapy

Participants needed: 62
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: ImmuneOncia Therapeutics Inc.Updated: Apr 24, 2026Locations: 3
Eligibility criteria

Signed ICF [+23]

Treatment with nonpermitted drugs [+10]

Status: Recruiting

A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

The goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.

Participants needed: 30
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: ImmuneOncia Therapeutics Inc.Updated: Apr 17, 2026Locations: 4
Eligibility criteria

Documented TMB-H:≥ 16 mut/Mb, determined by the TruSightTM Oncology 500 NGS pane... [+13]

Previously treated with an anti-PD-L1 or anti-PD-1 antibody [+4]